STRIKE A NERVE
agency: Unit 7
brand: Lyrica
client: Pfizer
photo from left: Steve Capp, chief creative officer, copywriter • Mickey Paxton, SVP, group creative director, art director • Jeff Harris, executive creative director • Paul Mellet, executive producer • Ross Quinn, chief collaboration officer
Pain is no laughing matter. But the team at Unit 7 managed to incorporate humor into its unbranded commercial for Pfizer's Lyrica in a way that brought the product closer to patients.
The campaign features the Nerve Man, a nefarious brute who torments diabetes sufferers with shooting, stabbing, burning pain. "People are dealing with this pain day in and day out," says Steve Capp, chief creative officer for Unit 7. "There is a fine line that you walk for anything dealing with pharmaceuticals. People's quality of life is affected, so will the Nerve Man be seen as humorous or are they going to be offended by it? We did our homework; we asked the questions. When we did the testing, people reacted in the right way."
Capp and teammate Mickey Paxton found initial inspiration for the Nerve Man concept in Trilogy of Terror, a series of three campy made-for-TV horror films that aired on ABC in the 1970s. In one of the films, a doll terrorizes actress Karen Black by repeatedly attacking her. While Unit 7 certainly didn't want to make a terrifying commercial, the team did want to communicate the idea of an enemy who can strike at any moment. Enter the Nerve Man.
The audition process was grueling, with nearly 100 actors lining up to get the part. But when the team met Schuler Hensley, they knew they had their man. "He just hit it right on the head and delivered exactly what we were looking for," says Capp. "It's a bit John Belushi, a bit Jack Black, a bit Lou Costello." (Currently, Hensley is appearing on Broadway in a star-making turn as the Monster in the musical Young Frankenstein.) The fact that Hensley is physically imposing also augments the message that diabetic nerve pain truly compromises one's quality of life and can't simply be brushed off as a minor nuisance.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.